Experimental Drug from Tetra Discovery Partners may Treat Traumatic Brain injury, trial shows

Print Page | Contact Us | Sign In | Join

News and Press: Member Organization News

Experimental Drug from Tetra Discovery Partners may Treat Traumatic Brain injury, trial shows

Friday, July 8, 2016 (0 Comments)
Posted by: Kate Oesterle

Share |

An experimental drug under development by Tetra Discovery Partners LLC has the potential to treat traumatic brain injury, according to the results of a pre-clinical trial.

In testing on rats, researchers at the University of Miami’s Traumatic Brain Injury Institute found that the Grand Rapids-based Tetra’s compound, known as PDE4, reduced chronic cognitive deficits after traumatic brain injury.

The results “suggest that PDE4B inhibition has the potential to improve learning and memory ability and overall functioning for people living with TBI (traumatic brain injury),” according to a statement today from the University of Miami and Tetra Discovery Partners.

Read full article.

« Back to Index

Creating Value

by delivering business-critical resources & bottom line savings

Building Networks

by connecting Michigan's bio-industry one member at a time

Impacting Policy

by influencing business growth through advocacy

Growing Talent

by creating opportunities that develop people & build organizations

	Edit This Favorite
Name:
Category:
Share:	Yes No, Keep Private

Edit This Favorite

Experimental Drug from Tetra Discovery Partners may Treat Traumatic Brain injury, trial shows